On this page
- This is a fast-changing area
- Quick Answer
- What Benefits Are We Hoping For?
- What Risks Are Common?
- Pancreatitis: What Is It?
- Gallbladder Problems
- Dehydration And Kidney Problems
- Low Blood Sugar
- Eyesight And Diabetes
- Surgery, Anaesthetic And Sedation
- Who Needs Extra Caution?
- The Wider Health Picture
- How To Reduce Risk
- Dr Mel’s Take
- Key Messages
- New To Mounjaro?
- Useful Sources
This is a fast-changing area
Safety advice may change as more people use these medicines. This article reflects UK product information and national guidance at the date shown below.
Last reviewed: 15 July 2026
A very reasonable question is: “I’ve heard Mounjaro can cause pancreatitis. Should I be worried?” The honest answer is that serious side effects can happen, but they are uncommon. The decision is about weighing possible benefits against possible risks for you.
Quick Answer
Mounjaro can be very helpful for some people. It can reduce hunger, quieten food noise, support weight loss, improve blood sugar and help reduce risks linked with obesity and metabolic disease.
But it is not risk-free. Common side effects are usually digestive. Less common but important risks include pancreatitis, gallbladder problems, dehydration, kidney problems, severe allergy, low blood sugar when combined with certain diabetes medicines, and issues around surgery or sedation.
The aim is not to pretend risks do not exist. The aim is to understand them clearly.
What Benefits Are We Hoping For?
Benefits are possibilities, not guarantees. Different people respond differently.
Hunger may feel quieter and fullness may arrive sooner.
Thoughts about food may feel less constant for some people.
Some people lose a meaningful amount of weight.
Blood sugar control may improve, especially in people with type 2 diabetes or prediabetes.
Weight loss and metabolic improvement may help blood pressure for some people.
Movement, breathlessness, sleep, confidence and quality of life may improve.
What Risks Are Common?
The most common side effects are digestive. These include nausea, diarrhoea, vomiting, stomach pain and constipation. Reflux, burping, sulphur burps, bloating, dry mouth and tiredness can also happen.
These are often more noticeable when starting treatment or after a dose increase, although individual responses vary.
For practical tips, read Common side effects of Mounjaro and what to do and Managing Mounjaro side effects.
Pancreatitis: What Is It?
The pancreas is an organ that helps with digestion and blood sugar control. Pancreatitis means inflammation of the pancreas. It is uncommon, but it can be serious.
Seek urgent medical advice if you develop:
- severe, persistent pain in the upper tummy
- pain that goes through to the back
- severe pain with vomiting or feeling very unwell
Stop taking Mounjaro and seek immediate medical help if this happens. If pancreatitis is confirmed, Mounjaro should not be restarted.
This does not mean every stomach ache is pancreatitis. But severe, persistent pain is not something to wait out at home.
Gallbladder Problems
Gallstones and gallbladder inflammation can happen during weight loss itself, as well as being reported with some weight-loss medicines. The gallbladder sits under the liver and helps digest fat.
Ask for urgent advice if you have severe right-sided upper tummy pain, pain with fever, yellowing of the skin or eyes, dark urine, pale stools, or you feel very unwell.
Dehydration And Kidney Problems
Vomiting and diarrhoea can lead to dehydration. Dehydration can sometimes affect kidney function, especially in people who are older, frail, already have kidney problems, or take certain medicines.
Do not push through repeated vomiting or diarrhoea. Sip fluids, consider oral rehydration, and seek advice if you cannot keep fluids down or you are passing very little urine.
Low Blood Sugar
Mounjaro on its own is less likely to cause low blood sugar. The risk is more important if it is used with insulin or sulphonylurea tablets such as gliclazide.
If you take diabetes medication, your prescriber may need to review doses and monitoring. Symptoms of low blood sugar can include shaking, sweating, hunger, confusion, palpitations, dizziness or feeling faint.
Eyesight And Diabetes
Vision problems are not a common side effect of Mounjaro. People with diabetes may already be at risk of diabetic eye disease, and changes in blood glucose can sometimes affect vision.
Tell your prescriber if you have diabetic retinopathy or macular oedema so that appropriate monitoring can be considered. Seek urgent medical advice for sudden vision loss, a rapid deterioration in vision, dark shadows or loss of part of your visual field, whatever the cause may be.
Surgery, Anaesthetic And Sedation
Mounjaro can slow stomach emptying. This matters if you are having surgery, an endoscopy, deep sedation or an anaesthetic, because food or fluid staying in the stomach may affect safety planning.
Tell your surgical, anaesthetic or endoscopy team that you use Mounjaro. Do not stop or restart medication around a procedure without following the advice you are given.
Who Needs Extra Caution?
Mounjaro may need extra discussion, delay or specialist advice if you:
- have had pancreatitis
- have gallstones or significant gallbladder disease
- have severe digestive problems or delayed stomach emptying
- have significant kidney disease or are at high risk of dehydration
- take insulin or sulphonylurea tablets
- are pregnant or planning pregnancy—Mounjaro should not be used during pregnancy and should be stopped at least 1 month before trying to conceive
- are breastfeeding or planning to breastfeed, as this needs an individual clinical discussion
- use oral contraception or oral progesterone as part of HRT
- have an active eating disorder or are struggling to eat safely
- are due to have surgery, sedation or an endoscopy
The Wider Health Picture
Medication risks are only one part of the decision. Obesity and metabolic disease can also affect health, and Mounjaro is one of several possible approaches to treatment and support.
Side effects, dehydration, pancreatitis, gallbladder problems, interactions and rare serious reactions.
Type 2 diabetes, high blood pressure, heart disease, stroke, fatty liver disease, sleep apnoea, joint pain and some cancers.
What matters is your personal risk, likely benefit, preferences and access to safe follow-up.
This is not about pressuring anyone into medication. It is about considering the likely benefits, risks, alternatives and your own preferences through shared decision making.
How To Reduce Risk
There should be a real medical assessment and follow-up.
Mention gallstones, pancreatitis, diabetes medicines, eating disorders, pregnancy plans and HRT.
If side effects are difficult, ask before moving up.
Enough protein, fibre, fluid and vitamins matter when appetite is low.
Do not borrow medication or buy from social media sellers.
Tell your prescriber and use the MHRA Yellow Card scheme.
Dr Mel’s Take
The question is not “is this risk-free?” Very few treatments are. The better question is: “Do the likely benefits outweigh the risks for this person, at this time, with safe follow-up?”
I think it is reasonable to be positive about Mounjaro while still being honest. For some people it can create space: less food noise, less constant restriction, and more room to build habits that support long-term health. But it still needs respect, monitoring and informed choice.
Key Messages
- Mounjaro can have real benefits, but it is not risk-free.
- Common side effects are usually digestive.
- Pancreatitis and gallbladder problems are uncommon but important to recognise.
- Sudden vision changes should always be taken seriously.
- The health risks of untreated obesity and metabolic disease also matter.
- A safe decision depends on your health, preferences, risk factors and follow-up.
New To Mounjaro?
Start with Starting Mounjaro: the basics for dosing, injection, storage and key safety information.
Useful Sources
Mounjaro KwikPen Patient Information Leaflet, emc
NICE TA1026: Tirzepatide for managing overweight and obesity
NICE: Prescribing, reviewing and stopping tirzepatide
MHRA: GLP-1 medicines—what you need to know
First published July 2026. Last reviewed: 15 July 2026. Planned review: October 2026, or earlier if MHRA/NICE/product information changes.
Prepared for the Pathfields Healthy Living Portal.